dr. sonpavde on remaining questions with immunotherapy in bladder cancer
Published 5 years ago • 184 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:57
dr. balar on remaining questions with immunotherapy in bladder cancer
-
1:19
dr. sonpavde on key data with immunotherapy in metastatic bladder cancer
-
1:24
dr. sonpavde on neoadjuvant immunotherapy in bladder cancer
-
0:52
dr. sonpavde on trials of immunotherapy in bladder cancer
-
2:03
dr. sonpavde on immunotherapy after progression in advanced bladder cancer
-
2:07
dr. sonpavde on emerging immunotherapy approaches in bladder cancer
-
0:47
copy of dr. sonpavde on key data with immunotherapy in metastatic bladder cancer
-
0:50
dr. sonpavde on immunotherapy combination studies in urothelial carcinoma
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
0:53
dr. sonpavde on immunotherapy plus chemotherapy in bladder cancer
-
1:05
dr. sonpavde on the biggest challenges in bladder cancer
-
1:10
dr. sonpavde on the potential for neoadjuvant immunotherapy in bladder cancer
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
1:08
dr. sonpavde on ongoing trials with immunotherapy for penile cancer
-
1:25
dr. sonpavde on the next steps for atezolizumab in urothelial carcinoma
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
1:58
dr. sonpavde on combining vegf/pd-1 inhibitors in metastatic urothelial carcinoma
-
1:08
dr. sonpavde on accelerated approval of erdafitinib in bladder cancer